Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Open Access
- 1 July 2017
- journal article
- review article
- Published by Elsevier BV in Cell Metabolism
- Vol. 26 (1), 71-93
- https://doi.org/10.1016/j.cmet.2017.06.018
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (670, 704, 1123, 57, 83, 1023, SPP1923)
- National Institutes of Health (RO1 HL112661)
This publication has 100 references indexed in Scilit:
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosisEMBO Molecular Medicine, 2012
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestineNature, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during ApoptosisImmunity, 2012
- NLRP3 inflammasomes link inflammation and metabolic diseaseTrends in Immunology, 2011
- NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for ColitisCell, 2011
- Hypoxia-Inducible Factors as Essential Regulators of InflammationPublished by Springer Science and Business Media LLC ,2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Oxidized phospholipids in control of inflammation and endothelial barrierTranslational Research, 2009
- Regulation of hexokinase binding to VDACJournal of Bioenergetics and Biomembranes, 2008